Drug Pipeline

ALN-APP Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-09 NCT07636811 A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06393712 A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy Cerebral Amyloid Angiopathy Recruiting
NCT07636811 A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down… Down Syndrome-Associated Alzheimer's Disease (DS-AD) Not Yet Recruiting
Phase 1
NCT05231785 A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD Early-Onset Alzheimer Disease Recruiting
Sponsors Running ALN-APP Trials
Alnylam Pharmaceuticals (3)
Disease Areas
Alzheimer's Disease (2)
Get alerts when ALN-APP trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free